Veteran private-equity investor focused on growth-stage technology and healthcare companies, specializing in buyouts, operational value creation and go-to-market scaling. Brandon Smith brings over a decade of cross-border investing and operating experience, having led platform investments, add-on acquisitions and board oversight across SaaS, digital health and enterprise software. Deeply involved in portfolio transformation, capital allocation and senior management recruitment, he is known for thesis-driven sourcing and exit execution. Investment remit typically targets $50m–$300m enterprise value companies and institutional LP relationships, with an emphasis on revenue growth, margin expansion and strategic M&A.
Veteran private-equity investor focused on growth-stage technology and healthcare companies, specializing in buyouts, operational value creation and go-to-market scaling. Brandon Smith brings over a decade of cross-border investing and operating experience, having led platform investments, add-on acquisitions and board oversight across SaaS, digital health and enterprise software. Deeply involved in portfolio transformation, capital allocation and senior management recruitment, he is known for thesis-driven sourcing and exit execution. Investment remit typically targets $50m–$300m enterprise value companies and institutional LP relationships, with an emphasis on revenue growth, margin expansion and strategic M&A.
Focuses on growth-stage technology and healthcare buyouts, prioritizing scalable SaaS, digital health, and enterprise software businesses where operational interventions and go-to-market scaling can unlock value. Applies a thesis-driven sourcing model, targets $50m–$300m enterprise value platforms, and pursues add-on M&A to accelerate consolidation. Capital allocation balances minority growth rounds with control buyouts to drive revenue growth and margin expansion over a 3–7 year exit horizon. Risk disciplined through active board oversight, management recruitment, and performance-linked operational KPIs to de-risk exits for institutional LPs.
Focuses on growth-stage technology and healthcare buyouts, prioritizing scalable SaaS, digital health, and enterprise software businesses where operational interventions and go-to-market scaling can unlock value. Applies a thesis-driven sourcing model, targets $50m–$300m enterprise value platforms, and pursues add-on M&A to accelerate consolidation. Capital allocation balances minority growth rounds with control buyouts to drive revenue growth and margin expansion over a 3–7 year exit horizon. Risk disciplined through active board oversight, management recruitment, and performance-linked operational KPIs to de-risk exits for institutional LPs.
| Trades 379 | Longs Won 314/379 82% | Profit Factor 63.45 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $471,432.07 |
| Average Win $153,195.14 | Best Trade (Aug 19) $8.5M | Sharpe Ratio -9.57 |
| Average Loss -$11,664.29 | Worst Trade (Dec 30) -$69,409.36 | Z-Score 25.17 (100%) |
| Commissions $0 | Avg. Trade Length 10m 4w 1d | Expectancy $124,921.1 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 17,544 | 15,789 | 14,035 | 12,281 | 10,526 | 8,772 | 7,018 | 5,263 | 3,509 | 1,754 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 8,101 | $2.03M | $2.5M | - | $472,591.19 | 23.28% | -7.354% |
ADBE Adobe Inc. | 1,055 | $248,836.98 | $264,182.55 | - | $15,345.57 | 6.17% | +1.013% |
ADI Analog Devices, Inc. | 703 | $223,652 | $258,289.23 | - | $34,637.23 | 15.49% | +0.202% |
AFBI Affinity Bancshares Inc. | 41,000 | $912,660 | $943,000 | - | $30,340 | 3.32% | 0.0 |
AFL Aflac Inc. | 2,478 | $256,324.76 | $315,895.44 | - | $59,570.68 | 23.24% | +0.094% |
AKRE Akre Focus ETF | 5,462 | $338,826.08 | $314,010.38 | - | -$24,815.7 | -7.32% | -0.087% |
AMGN Amgen Inc. | 1,245 | $324,496.61 | $479,524.2 | - | $155,027.59 | 47.77% | -0.64% |
APD Air Products and Chemicals, Inc. | 2,275 | $659,841.19 | $670,874.77 | - | $11,033.58 | 1.67% | -1.769% |
ASML ASML Holding N.V. New York Registry Shares | 250 | $200,348 | $407,250 | - | $206,902 | 103.27% | -1.359% |
AVUV Avantis U.S. Small Cap Value ETF | 38,944 | $3.75M | $4.88M | - | $1.13M | 30.13% | +0.032% |
BAC Bank of America Corporation | 5,825 | $256,009 | $360,858.75 | - | $104,849.75 | 40.96% | +0.356% |
BHLB Berkshire Hills Bancorp Inc | 22,100 | $663,000 | $663,000 | - | - | - | 0.0 |
BKNG Booking Holdings Inc. | 1,625 | $318,848.22 | $313,462.48 | - | -$5,385.74 | -1.69% | -0.176% |
BLK BlackRock, Inc. | 660 | $663,892.91 | $719,657.41 | - | $55,764.5 | 8.4% | -0.727% |
BRK-B Berkshire Hathaway Inc. | 1,300 | $602,224 | $665,002 | - | $62,778 | 10.42% | +0.365% |
BUSE First Busey Corporation | 10,000 | $252,700 | $308,600 | - | $55,900 | 22.12% | -1.343% |
C Citigroup Inc. | 16,100 | $1.83M | $2.13M | - | $306,544 | 16.79% | +0.098% |
COR Cencora, Inc. | 994 | $223,332 | $309,471.96 | - | $86,139.96 | 38.57% | -0.285% |
COST Costco Wholesale Corporation | 253 | $231,816.21 | $240,828.17 | - | $9,011.96 | 3.89% | -0.239% |
CSCO Cisco Systems, Inc. | 16,081 | $952,002.29 | $1.87M | - | $913,232.9 | 95.93% | +2.14% |